Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.61 | 1.77 | 1.5 | 18487 | 1.61495862 | CS |
| 4 | -0.19 | -10.5555555556 | 1.8 | 1.81 | 1.5 | 11888 | 1.65474646 | CS |
| 12 | 0.03 | 1.89873417722 | 1.58 | 2.18 | 1.5 | 12764 | 1.82208337 | CS |
| 26 | -0.45 | -21.8446601942 | 2.06 | 2.49 | 1.47 | 10108 | 1.85972976 | CS |
| 52 | -0.38 | -19.0954773869 | 1.99 | 3.2 | 1.47 | 11170 | 2.14863249 | CS |
| 156 | -1.6 | -49.8442367601 | 3.21 | 4.45 | 1.47 | 14211 | 2.78840427 | CS |
| 260 | -1.6 | -49.8442367601 | 3.21 | 4.45 | 1.47 | 14211 | 2.78840427 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
